As ABC transporters are downstream of Nrf2, the absence of Nrf2 enhanced the sensitivity of osteosarcoma to doxorubicin, cisplatin, and sorafenib and resulted in decreased expression of ABCC3, ABCC4, and ABCG2 [13]. The gene discussed is NFE2L2; the disease is osteosarcoma.